Faculty Opinions recommendation of Appropriate non-carbapenems are not inferior to carbapenems as initial empirical therapy for bacteremia caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: a propensity score weighted multicenter cohort study.

2018 ◽  
Author(s):  
Theo Zaoutis
Keyword(s):  
Cohort Study ◽  
Propensity Score ◽  
Empirical Therapy ◽  
Beta Lactamase ◽  
Multicenter Cohort Study ◽  
Extended Spectrum Beta Lactamase ◽  
Multicenter Cohort ◽  
Extended Spectrum ◽  
Initial Empirical Therapy

Infections in Patients Colonized With Extended-spectrum Beta-Lactamase-Producing Enterobacterales: A Retrospective Cohort Study

2020 ◽  
Author(s):  
Isabelle Vock ◽  
Lisandra Aguilar-Bultet ◽  
Adrian Egli ◽  
Pranita D Tamma ◽  
Sarah Tschudin-Sutter
Keyword(s):  
Cohort Study ◽  
Retrospective Cohort Study ◽  
Retrospective Cohort ◽  
Treatment Recommendations ◽  
Hospitalized Patients ◽  
Beta Lactamase ◽  
Extended Spectrum Beta Lactamase ◽  
Patient Level ◽  
Empiric Treatment ◽  
Extended Spectrum

Abstract We investigated relative proportions of extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-PE) versus non-ESBL-PE (nESBL-PE) infections in ESBL-PE colonized patients. ESBL-PE are not causative for the majority of infections in hospitalized patients colonized with ESBL-PE. Site of infection and patient-level exposures may be useful predictors of nESBL-PE infections, potentially guiding empiric treatment recommendations.

Sign in / Sign up

Export Citation Format

Share Document